描述
Study design and patient enrollment for the IBS-diarrhea symptom exacerbation cohort are outlined, detailing the collection of fecal, salivary, and dental plaque samples from participants during baseline and flare periods.
Figure 1
FlowchartSource Paper
Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.Cite This Figure
![Figure 1: Study design and patient enrollment for the IBS-diarrhea symptom exacerbation cohort are outlined, detailing the collection of fecal, salivary, and dental plaque samples from participants during baseline and flare periods.]() > Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." *Journal of gastroenterology*, 2022. PMID: [35908139](https://pubmed.ncbi.nlm.nih.gov/35908139/)
<figure> <img src="" alt="Study design and patient enrollment for the IBS-diarrhea symptom exacerbation cohort are outlined, detailing the collection of fecal, salivary, and dental plaque samples from participants during baseline and flare periods." /> <figcaption>Figure 1. Study design and patient enrollment for the IBS-diarrhea symptom exacerbation cohort are outlined, detailing the collection of fecal, salivary, and dental plaque samples from participants during baseline and flare periods.<br> Source: Yukari Tanaka et al. "Omics profiles of fecal and oral microbiota change in irritable bowel syndrome p." <em>Journal of gastroenterology</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35908139/">35908139</a></figcaption> </figure>